« Return to News | Drug Sponsors

Merck to cut 12K jobs

Friday, July 29, 2011 12:55 PM

Merck plans to slash thousands more jobs by late 2015 to wring out additional annual cost savings of up to $1.5 billion that can be plowed back into research and deal making, according to Reuters.

The U.S. drug maker cut 6,500 jobs last year, reducing its workforce to 91,000 employees. The company said it will reduce its workforce by an additional 12% to 13% from the 100,000 employees it had at the end of 2009 after buying Schering-Plough for $41 billion.

A company spokesman declined to peg the actual number of job cuts, saying they would be somewhat offset by new hires in strategic growth areas, such as emerging markets. "The new phase of restructuring will create an additional $1.3 billion to $1.5 billion in annual cost savings," Merck spokesman David Caouette said.

The company eliminated almost 12,500 positions in 2010 but hired about 6,000. "I think we're going to see other firms continue to expand their cost-reduction programs," Morningstar analyst Damien Conover said.

Merck has vowed to maintain research and development spending at stable levels, rather than slash research costs to meet earnings targets. But the company shaved the high end of its 2011 research budget by $100 million, to between $8 billion and $8.3 billion.

With the new job cuts, Merck's restructuring program will yield annual savings of $4 billion to $4.6 billion by the end of 2015, compared with an earlier estimate of $2.7 billion to $3.1 billion by late 2012, Merck said.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.